A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
Clinical trial NCT04546009 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04546009
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2026-01-30
- Enrollment
- 992
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.